Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial
J. Clin. Oncol 2022 Apr 08;[EPub Ahead of Print], MM Gounder, AA Razak, N Somaiah, S Chawla, J Martin-Broto, G Grignani, SM Schuetze, B Vincenzi, AJ Wagner, B Chmielowski, RL Jones, RF Riedel, S Stacchiotti, ET Loggers, KN Ganjoo, A Le Cesne, A Italiano, X Garcia Del Muro, M Burgess, S Piperno-Neumann, C Ryan, MF Mulcahy, C Forscher, N Penel, S Okuno, A Elias, L Hartner, T Philip, T Alcindor, B Kasper, P Reichardt, L Lapeire, JY Blay, C Chevreau, CM Valverde Morales, GK Schwartz, JL Chen, H Deshpande, EJ Davis, G Nicholas, S Gröschel, H Hatcher, F Duffaud, AC Herráez, RD Beveridge, G Badalamenti, M Eriksson, C Meyer, M von Mehren, BA Van Tine, K Götze, F Mazzeo, A Yakobson, A Zick, A Lee, AE Gonzalez, A Napolitano, MA Dickson, D Michel, C Meng, L Li, J Liu, O Ben-Shahar, DR Van Domelen, CJ Walker, H Chang, Y Landesman, JJ Shah, S Shacham, MG Kauffman, S AttiaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.